Analyst Reco. IDEXX Laboratories, Inc.

Equities

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-19 pm EDT			5-day change	1st Jan Change
517.06 ^USD	+1.13%		+4.03%	-6.84%

Sep. 04	IDEXX Laboratories, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 11:30 AM
Aug. 15	IDEXX Laboratories, Inc. - Analyst/Investor Day

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Piper Sandler Adjusts Price Target on IDEXX Laboratories to $520 From $600	Aug. 14	MT
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $607 From $641	Aug. 14	MT
BTIG Starts IDEXX Laboratories With Buy Rating, $580 Price Target	Jul. 25	MT
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $589 From $596, Maintains Overweight Rating	Jul. 16	MT
Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $520	Jun. 24	MT
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620	May. 14	MT
BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653	May. 02	MT
Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675	May. 02	MT
Stifel Adjusts Price Target on IDEXX Laboratories to $520 From $570	May. 02	MT
Barclays Adjusts Price Target on IDEXX Laboratories to $570 From $655	May. 02	MT
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460	May. 02	MT
BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating	Apr. 30	MT
Analyst recommendations: Coinbase, Fortinet, Nike, Chipotle, Nvidia...	Feb. 16
JPMorgan Adjusts Price Target on IDEXX Laboratories to $630 From $600, Maintains Overweight Rating	Feb. 06	MT
Morgan Stanley Lifts PT on IDEXX Laboratories to $620 From $600 After 'Impressive' Q4 2023 Upside, 'Solid' 2024 Guide; Overweight Kept	Feb. 06	MT
Barclays Adjusts Price Target on IDEXX Laboratories to $655 From $605, Keeps Overweight Rating	Feb. 06	MT
Stifel Adjusts Price Target on IDEXX Laboratories to $570 From $525, Keeps Hold Rating	Feb. 06	MT
Piper Sandler Downgrades IDEXX Laboratories to Neutral From Overweight, Price Target is $525	Jan. 30	MT
Analyst recommendations: Adobe, AMD, Astrazeneca, Home Depot, Netflix...	Jan. 30
Goldman Sachs Hikes Price Target on IDEXX Laboratories to $650 From $500, Maintains Buy Rating	Jan. 17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Idexx Laboratories: Superior growth prospects

March 11, 2024 at 01:18 pm EDT